Literature DB >> 30609581

Stepwise targeted matching strategy from in vitro to in vivo based on ultra-high performance liquid chromatography tandem mass spectrometry technology to quickly identify and screen pharmacodynamic constituents.

Guifang Feng1, Yufei Sun1, Shu Liu2, Fengrui Song3, Zifeng Pi3, Zhiqiang Liu4.   

Abstract

The study of in vivo pharmacodynamic constituents (PCs) of traditional Chinese medicine (TCM) is important for providing new clues for TCM applications in clinical therapies in modern medicine. However, detecting and identifying PCs from complex biological samples remain a challenge. In this study, a practical and novel stepwise targeted matching and longitudinal analysis strategy from in vitro to in vivo was developed. This strategy combined with ultra-high performance liquid chromatography tandem mass spectrometry was applied to quickly discover PCs in TCM. This approach was developed based on a core perception that all drugs taken orally might be transformed progressively and orderly from the intestinal tract, liver, and blood to the target organ. Based on this core perception, stepwise targeted matching was orderly and efficiently accomplished by multiple screening processes that were based on a stepwise enriched in-house library. Ginseng (Panax ginseng) was set as the example of herbal medicine for validating the reliability and availability of this approach. By applying this novel strategy to the stepwise screening of metabolites, we successfully identified 113 metabolites, among which 59 compounds were defined as prototypes. Based on the in vivo metabolites, network pharmacology analysis was applied to screen the PCs of ginseng and clarified the action mechanism of ginseng for the treatment of Alzheimer's disease (AD). A total of 27 herbal constituents and 64 related targets shared commonly by compounds and AD were integrated via target network pharmacology analysis. These results demonstrated that this original approach will greatly improve high-throughput screening of metabolites and PCs on AD. It also can explicate the mechanism of action of TCM. Furthermore, this strategy is practicable to identify metabolites and screen PCs in other herbal medicines.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ginseng; Pharmacodynamic constituents; Stepwise targeted matching strategy; Ultra–high performance liquid chromatography tandem mass spectrometry

Mesh:

Substances:

Year:  2018        PMID: 30609581     DOI: 10.1016/j.talanta.2018.10.074

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  4 in total

1.  An Integrated Approach to Characterize Intestinal Metabolites of Four Phenylethanoid Glycosides and Intestinal Microbe-Mediated Antioxidant Activity Evaluation In Vitro Using UHPLC-Q-Exactive High-Resolution Mass Spectrometry and a 1,1-Diphenyl-2-picrylhydrazyl-Based Assay.

Authors:  Xiaoming Wang; Xiaoyan Chang; Xiaomei Luo; Meifeng Su; Rong Xu; Jun Chen; Yi Ding; Yue Shi
Journal:  Front Pharmacol       Date:  2019-07-25       Impact factor: 5.810

2.  Discovering the Major Antitussive, Expectorant, and Anti-Inflammatory Bioactive Constituents in Tussilago Farfara L. Based on the Spectrum-Effect Relationship Combined with Chemometrics.

Authors:  Liu Yang; Hai Jiang; Song Wang; Ajiao Hou; Wenjing Man; Jiaxu Zhang; Xinyue Guo; Bingyou Yang; Haixue Kuang; Qiuhong Wang
Journal:  Molecules       Date:  2020-01-31       Impact factor: 4.411

3.  Integrated Strategy From In Vitro, In Situ, In Vivo to In Silico for Predicting Active Constituents and Exploring Molecular Mechanisms of Tongfengding Capsule for Treating Gout by Inhibiting Inflammatory Responses.

Authors:  Wenning Yang; Xiaoquan Jiang; Jingtong Liu; Dongying Qi; Zhiqiang Luo; Guohua Yu; Xueyan Li; Muli Sen; Hongjiao Chen; Wei Liu; Yang Liu; Guopeng Wang
Journal:  Front Pharmacol       Date:  2021-11-29       Impact factor: 5.810

4.  Corydalis Rhizoma as a model for herb-derived trace metabolites exploration: A cross-mapping strategy involving multiple doses and samples.

Authors:  Chanjuan Yu; Fengyun Wang; Xinyue Liu; Jiayan Miao; Siqi Tang; Qin Jiang; Xudong Tang; Xiaoyan Gao
Journal:  J Pharm Anal       Date:  2020-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.